Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes

Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes

US Patent 6982260 · Granted Jan 3, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted tetrahydropyridine derivatives as IDO-1 inhibitors and uses thereof2020
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-ass2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020
Boron-containing small molecules2020
2-(pyridin-2-ylamino)-pyrido[2,3-D]pyrimidin-7-ones2019
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamm2019
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonis2019
Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associate2018
Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof2018
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonis2017
Boron-containing small molecules2017
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ ac2017